Status:
TERMINATED
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Lead Sponsor:
Vanderbilt University
Conditions:
Bladder Cancer
Hemostasis
Eligibility:
All Genders
19-85 years
Phase:
NA
Brief Summary
Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.
Eligibility Criteria
Inclusion
- Muscle invasive bladder cancer
- Male/Female gender
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00802633
Start Date
November 1 2008
End Date
June 1 2012
Last Update
February 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232